Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and sustained access to medication used to treat severe chronic pain and spasticity.
To address these near-term supply chain disruptions, AIS Healthcare is increasing capacity at its pharmacies in Texas and Mississippi, which were not impacted by the hurricanes. This additional production capacity is intended to meet the demand of physicians and patients who use other pharmacies and may be struggling to access their medication.
“Our thoughts are with all the communities in the Southeast that have experienced immense tragedy and destruction over the last several weeks,” said Simon Castellanos, CEO of AIS Healthcare. “We see it as our responsibility to support physicians and patients in the one area we can – ensuring continuity of care by making essential medications available. Our pharmacy teams have been working around the clock to add capacity and respond to physicians and patients who cannot wait to have their next prescription filled. I’m proud of the work we have done and believe it is absolutely crucial we take action to provide essential medication in times of crises. We are committed to doing whatever is necessary to help all physicians, patients, and our industry during this difficult time.”
AIS Healthcare is dedicated to prioritizing the health and safety of all patients in need of care during this period of recovery. To support those who are recovering from hurricanes Milton and Helene, the American Red Cross is accepting donations here.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Dallas, TX- AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).
The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion suite setting. This new immunoglobulin (Ig) therapeutic option will expand AIC’s ability to better serve PI patients.
“We are excited to add ALYGLO™ to our expansive list of Ig infusion therapies,” said Jud Hall, President of AIC. “AIC is proud to partner with GC Biopharma to offer this extra-purified IVIg replacement therapy as another treatment option to patients nationwide”, added Stan Singley, Vice President of Trade & Procurement.”
Approved by the U.S Food and Drug Administration in 2023, ALYGLO™ is now available at all AIC locations (Valdosta, GA; Birmingham, AL; Panama City, FL; Cockeysville, MD; and Dallas, TX).
Like all AIC patients, those with PI will receive a high level of care from AIC, including 24/7 access to clinical and support staff. Every patient is assigned a dedicated team of professionals, including clinical pharmacists, home infusion nurses, RN clinical review specialists, and patient access specialists to provide support throughout the treatment process.
For physicians, AIC is more than a specialty pharmacy. We are a full-service care delivery partner, and we have contracts with multiple immunoglobulin suppliers, like GC Biopharma. These contracts help us ensure prescribed therapies are always in stock. We also work directly with patients, insurance companies, and physician offices to secure all needed insurance authorizations and approvals.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
As the leading provider of infusion care solutions and targeted drug delivery, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
GC Biopharma is a global biopharmaceutical company, and a pioneer in the field of specialty pharmaceuticals. It is committed to improving the lives of people around the world and has built a global network of professionals and facilities to make this vision a reality.
GC Biopharma manufactured its first plasma-derived therapy in South Korea in 1971. Since then, the company has grown to become one of the top pharmaceutical manufacturers of plasma therapeutics in the world, distributing to more than 50 countries.
Throughout its history, which spans more than half a century, GC Biopharma has focused heavily on plasma-derived drug products. With one of the largest plasma manufacturing facilities in the world, it is devoted to developing new drugs to achieve its mission and vision.
CONTACT:
Jud Hall
877.443.4006
Stan Singley to serve as Vice President of Trade & Procurement for AIC
Dallas, Texas – AIC, a division of AIS Healthcare, today announced the hiring of Stan Singley as Vice President of Trade and Procurement. In this role, Stan will help drive AIC’s growth and expansion strategy in partnering with pharmaceutical manufacturers to gain limited distribution and sole source access for specialty drugs.
“We are thrilled to welcome a highly respected industry veteran with more than 20+ years of experience in immunology and rare diseases,” said Jud Hall, President at AIC. “Stan will bring a valuable perspective in partnering with internal and external stakeholders as we further develop and execute our trade strategy.”
Recently, Singley served as National Account Manager for Grifols USA, where he was responsible for partnering with key stakeholders to develop and execute channel strategy with key biological distributors, national specialty pharmacies, GPOs and health systems for their plasma-derived & hyperimmune products. Prior to Grifols, Stan was a successful sales professional and manager, culminating in his role as National Accounts Director, over the course of 12 years with Baxter BioScience. In this role, he successfully managed and continued to grow their plasma-derived, recombinant, oncology and biosurgery businesses.
“I’m excited to join the nationally accredited home infusion teams at AIC to further enhance the company’s efforts to advance chronic, rare and specialty therapies requiring complex clinical management,” said Stan Singley, Vice President of Trade & Procurement for AIC. “I truly believe, when the stakes are high for patients, that AIC can rise to the occasion with our comprehensive and differentiated care model and teams.”
Singley holds a Bachelor of Science in Business Administration degree from the University of Alabama.
AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers. Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2023 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program.
URAC is one of the nation’s leading independent health care accreditation organizations, with certification programs that set the highest standards in quality and safety.
Recently, URAC developed the Leaders in Performance Measurement awards program to highlight the URAC-accredited organizations that are using performance measurement to improve the health and well-being of the populations they serve. Their Pioneer Award recognizes the commitment of AIS Healthcare to promote trust in the quality of care delivered through performance measurement activities.
“We are humbled and honored to have been named a 2023 Pioneer by URAC,” said Simon Castellanos, AIS Healthcare CEO. “This recognition is a testament to the dedication and cohesiveness of our entire company. I could not be prouder of this team and their unwavering commitment to ensuring quality, sterility, and excellence across all our pharmacy operations.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
AIS Healthcare is also dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers.
Learn more at aiscaregroup.com
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize May as National Nurses Month. This month and throughout the year, AIS Healthcare celebrates the dedication of nurses who devote themselves to protecting and enhancing the well-being of those in need of care.
Nurses play a critical role in healthcare delivery in the United States and across the world. Thanks to advancements in medical science and technology, their role has expanded, often serving as a first point of contact for patients. AIS Healthcare nurses hold certifications in specialty infusion care and undergo advanced and ongoing clinical training, allowing them to provide patients with the best possible care. AIS Healthcare’s Advanced Nursing Solutions team is led by experienced professionals who understand what it takes to advance quality of life and improve health outcomes for patients afflicted with chronic pain and complex medical conditions.
“National Nurses Month gives us an opportunity to celebrate the pivotal role of nurses and their commitment to improving patient lives,” said Simon Castellanos, CEO of AIS Healthcare. “AIS Healthcare’s nurses deliver comprehensive care services and build strong connections and relationships that enable patients to better thrive in their communities and homes. We are grateful for their selfless dedication today and every day.”
AIS Healthcare’s Advanced Infusion Care (AIC) and TDD divisions utilize innovative healthcare solutions to manage patients’ needs. Collaboration between physicians and the AIS nursing team ensures the efficient delivery of patient-specific services and enhances the care experience for patients managing complex conditions.
Nurses change patient lives for the better. During National Nurses Month and throughout the year, AIS Healthcare encourages individuals, communities, and organizations to show their appreciation for nurses. To learn more about AIS Healthcare’s leading nursing program, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize the week of April 29 as Patient Experience Week. AIS Healthcare provides comprehensive care services for patients across the country and works to ensure health practices meet or exceed state and industry standards. These practices allow AIS to enhance the patient experience and obtain the best possible healthcare outcomes.
Established in 2014, Patient Experience Week is a time for the healthcare community – nurses, doctors, administrative staff, executives, and patients alike – to show appreciation for the industry professionals who commit themselves to making the patient experience safe and comfortable for all.
“AIS Healthcare is pleased to recognize Patient Experience Week and is grateful for our staff who dedicate their time, energy, and care to the patients we are proud to serve,” said Simon Castellanos, CEO of AIS Healthcare. “From our 24/7 on-call nursing and pharmacy services to our in-home personalized care, we are dedicated to making patients feel comfortable and cared for.”
AIS Healthcare uses innovative healthcare solutions to make the treatment process intuitive and helpful for all. AIS services act as an extension of physicians’ practices, enhancing the care experience for both patients and providers.
AIS maintains the highest possible quality of medications and carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care.
To learn more about AIS Healthcare’s services, visit here.
About AIS Healthcare
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly devote their time and energy to ensure the health and well-being of those in need of care.
Physicians are vital to this country’s healthcare system, offering essential services to millions of individuals facing chronic illnesses and complex conditions. The physicians AIS Healthcare partners with are integral to delivering the highest quality care to vulnerable patient populations across the country. Collaboration between physicians and AIS Healthcare ensures that patients receive their specialized medications in a timely and efficient manner. AIS is proud to work with doctors to advance the quality of patient care and improve lives in the process.
“National Physicians Week is an opportunity to recognize the never-ending dedication and hard work of doctors across the country” said Simon Castellanos, CEO of AIS Healthcare. “At AIS Healthcare, we work with doctors every day to enhance the quality of care for the patients we serve. Today, we celebrate their countless contributions to patients and communities.”
AIS Healthcare uses innovative healthcare solutions to make the treatment process intuitive and helpful for all. AIS services act as an extension of physicians’ practices, enhancing the care experience for both patients and providers.
During National Physicians Week, AIS Healthcare encourages everyone to show their appreciation for the physicians in their lives. Whether through a kind gesture or a heartfelt thank you, this week is an opportunity to show our appreciation for the selflessness and dedication of the nation’s doctors. To learn more about AIS Healthcare and our work with doctors in supporting patients nationwide, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Dallas, Texas – AIC, a division of AIS Healthcare, now offers GLASSIA and ARALAST NP, manufactured by Takeda, for the treatment of adult patients with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-antitrypsin deficiency).
The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting. The addition of these therapy options expands AIC’s ability to better serve patients with alpha1-antitrypsin deficiency.
“We’re excited and proud to be able to add Takeda’s Alpha₁ therapies to our growing portfolio of infusion therapies,” said Jud Hall, President at AIC. “The addition of GLASSIA and ARALAST NP can help us provide patients with more options to meet individual treatment needs.”
Approved by the U.S. Food and Drug Administration (FDA) in 2010 and 2002, respectively, GLASSIA and ARALAST NP are Alpha1-Proteinase Inhibitors (Human) (Alpha1-PI) indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI. ARALAST NP increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1-PI.
The effect of augmentation therapy with GLASSIA, ARALAST NP, or any Alpha1-PI product on pulmonary exacerbations and on the progression of emphysema in Alpha1-PI deficiency has not been conclusively demonstrated in randomized, controlled clinical trials. Clinical data demonstrating the long-term effects of chronic augmentation and maintenance therapy of individuals with GLASSIA or ARALAST NP are not available. GLASSIA and ARALAST NP are not indicated as therapies for lung disease in patients in whom severe Alpha1-PI deficiency has not been established.
Both GLASSIA and ARALAST NP are now available at all AIC locations (Valdosta, Georgia; Birmingham, Alabama; Panama City, Florida; Dallas, Texas).
Like all AIC patients, those with alpha1-antitrypsin deficiency will receive a high level of care from AIC, including 24/7 access to clinical and support staff.
Every patient is assigned a dedicated team of professionals, including clinical pharmacists, home infusion nurses, RN clinical review specialists and patient onboarding specialists to provide support throughout the treatment process.
For providers, AIC is a full-service care delivery partner. We also work directly with patients, insurance companies, and provider offices to secure all needed insurance authorizations and approvals.
AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.
Contact:
Simon Castellanos
877.443.4006Well-Being First
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize the week of March 10th as Patient Safety Awareness Week. Established in 2002, this week is an opportunity to highlight the importance of equipping healthcare professionals and the general public with the knowledge needed to secure the most optimal health services and outcomes.
Some of the most common mistakes that can lead to patient harm are the result of system or process failures. Making the proper investments in patient safety can positively impact health outcomes, reduce overall healthcare costs, and earn the trust of patients in the healthcare system. At AIS Healthcare, patient safety is the top priority, which is why AIS meets and exceeds state and industry standards to produce patient-specific prescriptions of the highest quality and sterility. AIS uses a proven, proprietary process that combines aseptic processing with terminal sterilization on patient-specific prescriptions to achieve higher sterility assurance and extended Beyond-Use Dates (BUD).
“AIS Healthcare is proud to recognize Patient Safety Awareness Week and remains committed to elevating patient safety in every facet of our business,” said Simon Castellanos, CEO of AIS Healthcare. “Every day, the patients we serve entrust us with their care. It is our responsibility to take the time and make the investments to ensure their safety is put first in everything we do.”
AIS Healthcare ships more than 145,000 patient-specific prescriptions annually to all 50 states and is committed to advancing the quality of life and safety for all patients. AIS streamlines the care delivery process and goes above and beyond to maintain the highest possible quality of medications.
AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care. AIS Healthcare is committed to advancing quality and improving patient lives.
To learn more about AIS Healthcare’s services, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas -AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March as Brain Injury Awareness Month. This month reminds us of the importance of improving the quality of life for people impacted by brain injury through elevating awareness and advocacy and delivering the highest quality healthcare.
Brain injuries are widespread, and the impact on an individual and their family is not widely understood or appreciated. According to the CDC, more than 5.3 million individuals in the United States live with a brain injury or brain injury-related disability, and an average of 1.5 million traumatic brain injuries (TBI) occur each year. Post-brain injury treatment is a lifelong journey, often requiring specialized healthcare services and chronic pain treatment. AIS Healthcare is dedicated to ensuring patients living with a TBI and managing complex conditions can lead full, meaningful lives in their homes and local communities.
“The strength and resilience of the brain injury community are tremendous, and I welcome the strides made by the physical and behavioral health industries to elevate research, advocacy, and awareness on behalf of this important group,” said Simon Castellanos, CEO of AIS Healthcare. “This month and every month, we seek to empower individuals living with a brain injury by delivering the best possible in-home healthcare services and pain management solutions. We will always be an ally to this inspiring part of our larger patient community.”
Brain injuries often happen through absolutely no fault of the injured person. AIS Healthcare wants to remind everyone to take proper precautions to reduce the chance of brain injury by wearing seatbelts, helmets, and never driving impaired. To find more ways to support the brain injury community, contact your local brain injury association by visiting here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com